Mutations at the DNMT3A gene, encoding for the DNA methyltransferase 3 alpha, have been also described; however, the recurrence of this genetic alterations in JMML is lower than in other hematologic malignancies [64,90]. This evidence concerns the gene DNMT3A and hematologic disorder.